Titan Company approves stock unit scheme, director appointments
- Shareholders approved appointments of Dr. D Karthikeyan and Mr. K Vivekanandan as directors
- Three special resolutions passed for the 2026 Performance Based Stock Unit Scheme
- Promoter group voted 100% in favor of all five resolutions
- Total participation reached 86.15% of paid-up equity capital
- Institutional dissent peaked at 10.07% for Dr. Karthikeyan's appointment
*this image is generated using AI for illustrative purposes only.
Titan Company shareholders approved five resolutions through a postal ballot process on September 17, 2026. The approvals include the appointment of two independent directors and the implementation of a new employee stock unit scheme.
The voting process ran from August 19, 2026, to September 17, 2026. A total of 887,786,160 equity shares were eligible to vote as of the record date, August 7, 2026. Shareholders representing approximately 86% of the total paid-up capital participated in the remote e-voting process.
Director Appointments
Members approved the appointment of Dr. D Karthikeyan, IAS, and Mr. K Vivekanandan, IAS, as directors through ordinary resolutions.
The appointment of Dr. D Karthikeyan received 96.77% assent votes. Institutional investors showed slightly more dissent, with 10.07% voting against, while non-institutional public shareholders voted almost unanimously in favor (99.95%).
Mr. K Vivekanandan’s appointment secured stronger overall support, with 98.73% of votes cast in favor. Dissent was minimal across both institutional and non-institutional categories.
Employee Stock Unit Scheme
Three special resolutions related to the 'Titan Company Limited Performance Based Stock Unit Scheme, 2026' were approved. These resolutions cover grants for eligible employees of Titan and its subsidiaries, as well as authorization for the Titan Employee Stock Option Trust to acquire shares in the secondary market.
| Resolution Description | Type | Assent Votes (%) | Dissent Votes (%) |
|---|---|---|---|
| Appointment of Dr. D Karthikeyan | Ordinary | 96.77% | 3.23% |
| Appointment of Mr. K Vivekanandan | Ordinary | 98.73% | 1.27% |
| Stock Unit Scheme for Titan Employees | Special | 97.71% | 2.29% |
| Stock Unit Scheme for Subsidiary Employees | Special | 97.94% | 2.06% |
| Secondary Acquisition Authorization | Special | 98.30% | 1.70% |
The promoter group, holding 469,601,920 shares, voted in full support of all five resolutions. No promoter interest was declared in any of the agenda items.
What the Numbers Show
The voting data reveals a clear divergence in sentiment between institutional and retail investors regarding the appointment of Dr. D Karthikeyan. While non-institutional shareholders backed the resolution with near-unanimous support (99.95%), institutional investors registered the highest dissent rate among all resolutions at 10.07%. This suggests specific reservations among large block holders regarding this particular board addition, despite the resolution passing comfortably due to promoter backing.
Historical Stock Returns for Titan
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.38% | -3.28% | -4.26% | +18.34% | +36.11% | +129.57% |
How might the 10% institutional dissent against Dr. D Karthikeyan's appointment signal future friction in board governance or strategic decision-making?
What impact will the new Performance Based Stock Unit Scheme have on Titan's diluted earnings per share (EPS) and long-term employee retention metrics?
Given the IAS backgrounds of the new directors, how is Titan expected to navigate evolving regulatory landscapes or public sector interface requirements?
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
